Evidence map›Paper›PMID 24161567›Full record

ArticleJournal of dermatological science2014

Induction of a chloracne phenotype in an epidermal equivalent model by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) is dependent on aryl hydrocarbon receptor activation and is not reproduced by aryl hydrocarbon receptor knock down.

Alison R Forrester, Martina S Elias, Emma L Woodward, Mark Graham, Faith M Williams, Nick J Reynolds

Open access · hybridAbstract readComparative Study
In one paragraph

Article in Journal of dermatological science, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
3.5field-weighted citation impact, top 8% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Endocrine-disrupting chemicals and skin manifestations.Reviews in endocrine & metabolic disorders · 2016
    Review
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Alison R ForresterDermatological Sciences, 2nd Floor Leech Building, Medical Science, Institute of Cellular Medicine, Newcastle University, NE2 4HH, United Kingdom. Electronic address: a.forrester@tigem.it.
Martina S EliasDermatological Sciences, 2nd Floor Leech Building, Medical Science, Institute of Cellular Medicine, Newcastle University, NE2 4HH, United Kingdom. Electronic address: m.s.elias@newcastle.ac.uk.
Emma L WoodwardDermatological Sciences, 2nd Floor Leech Building, Medical Science, Institute of Cellular Medicine, Newcastle University, NE2 4HH, United Kingdom. Electronic address: e.l.woodward@ncl.ac.uk.
Mark GrahamGlobal Safety Assessment, Alderley Park, AstraZeneca, Cheshire, United Kingdom. Electronic address: mark.j.graham@me.com.
Faith M WilliamsToxicology, Institute of Cellular Medicine, Newcastle University, NE1 7RU, United Kingdom. Electronic address: faith.williams@ncl.ac.uk.
Nick J ReynoldsDermatological Sciences, 2nd Floor Leech Building, Medical Science, Institute of Cellular Medicine, Newcastle University, NE2 4HH, United Kingdom. Electronic address: nick.reynolds@ncl.ac.uk.
Newcastle University · GBAstraZeneca (United Kingdom) · GB

Funding

Biotechnology and Biological Sciences Research Council
6 · The paper itself

Abstract

background2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) is a potent activator of the aryl hydrocarbon receptor (AhR) and causes chloracne in humans. The pathogenesis and role of AhR in chloracne remains incompletely understood.

objectiveTo elucidate the mechanisms contributing to the development of the chloracne-like phenotype in a human epidermal equivalent model and identify potential biomarkers.

methodsUsing primary normal human epidermal keratinocytes (NHEK), we studied AhR activation by XRE-luciferase, AhR degradation and CYP1A1 induction. We treated epidermal equivalents with high affinity TCDD or two non-chloracnegens: β-naphthoflavone (β-NF) and 2-(1'H-indole-3'-carbonyl)-thiazole-4-carboxylic acid methyl ester (ITE). Using Western blotting and immunochemistry for filaggrin (FLG), involucrin (INV) and transglutaminase-1 (TGM-1), we compared the effects of the ligands on keratinocyte differentiation and development of the chloracne-like phenotype by H&E.

resultsIn NHEKs, activation of an XRE-luciferase and CYP1A1 protein induction correlated with ligand binding affinity: TCDD>β-NF>ITE. AhR degradation was induced by all ligands. In epidermal equivalents, TCDD induced a chloracne-like phenotype, whereas β-NF or ITE did not. All three ligands induced involucrin and TGM-1 protein expression in epidermal equivalents whereas FLG protein expression decreased following treatment with TCDD and β-NF. Inhibition of AhR by α-NF blocked TCDD-induced AhR activation in NHEKs and blocked phenotypic changes in epidermal equivalents; however, AhR knock down did not reproduce the phenotype.

conclusionLigand-induced CYP1A1 and AhR degradation did not correlate with their chloracnegenic potential, indicating that neither CYP1A1 nor AhR are suitable biomarkers. Mechanistic studies showed that the TCDD-induced chloracne-like phenotype depends on AhR activation whereas AhR knock down did not appear sufficient to induce the phenotype.

Indexed as

Gene Knockdown TechniquesBasic Helix-Loop-Helix Proteinsbeta-NaphthoflavoneCell DifferentiationCells, CulturedChloracneCytochrome P-450 CYP1A1Dose-Response Relationship, DrugEnzyme InductionEpidermisFilaggrin ProteinsHumansIndolesIntermediate Filament ProteinsKeratinocytesLigands2-(1'H-indole-3'-carbonyl)thiazole-4-carboxylic acid methyl esterAHR protein, humanBasic Helix-Loop-Helix Proteinsbeta-NaphthoflavoneCYP1A1 protein, humanCytochrome P-450 CYP1A1Filaggrin ProteinsFLG protein, humanIndolesIntermediate Filament ProteinsinvolucrinLigandsPolychlorinated DibenzodioxinsProtein PrecursorsReceptors, Aryl HydrocarbonThiazolestransglutaminase 1Transglutaminases2-(1′H-indole-3′-carbonyl)-thiazole-4-carboxylic acid methyl ester2,3,7,8-tetrachlorodibenzo-p-dioxinAhRAHRRaryl hydrocarbon receptorAryl hydrocarbon receptoraryl hydrocarbon repressor proteinCYP1A1cytochrome P450 1A1Epidermal equivalentITEKeratinocyteTCDDTGM-1transglutaminase-1xenobiotic response elementXREα-naphthoflavoneα-NFβ-naphthoflavoneβ-Naphthoflavoneβ-NF

Identifiers

PMID24161567
PMCPMC3885976
OpenAlexW2143480503

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.